SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999480-24-000020
Filing Date
2024-05-14
Accepted
2024-05-14 16:25:42
Documents
14
Period of Report
2024-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alto-20240514.htm   iXBRL 8-K 26165
2 EX-99.1 exhibit991-earningsrelease.htm EX-99.1 55329
  Complete submission text file 0001999480-24-000020.txt   218439

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alto-20240514.xsd EX-101.SCH 1928
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alto-20240514_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alto-20240514_pre.xml EX-101.PRE 13061
17 EXTRACTED XBRL INSTANCE DOCUMENT alto-20240514_htm.xml XML 2820
Mailing Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022
Business Address 369 SOUTH SAN ANTONIO RD. LOS ALTOS CA 94022 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

IRS No.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 24944792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)